Hemometabolic vs. Hemodynamic Cardiogenic Shock – Jacob Jentzer, MD​

Is IABP Appropriate as a First Line or Stabilization Tool? – David Baran, MD, FSCAI​

Who Are the Right Patients? Looking at Patients and Timing – Arnold Seto, MD, FSCAI​

Q&A with Moderated Panel Discussion​

	David Baran, MD, FSCAI		Jacob C. Jentzer, MD
	Arnold Seto, MD, MPA, FSCAI

This internet enduring activity is derived from a live activity, which was supported by an unrestricted educational grant from Getinge. No in-kind commercial support was received.

As a provider of continuing medical education through the Accreditation Council for Continuing Medical Education (ACCME), it is the Society’s policy to ensure balance, independence, objectivity, and scientific rigor in all its activities. All participating faculty, course directors, planning committee members and staff are required to disclose to SCAI any relevant financial relationships. SCAI identifies relevant conflicts of interest and resolves them before the activity begins.

Planning Process
SCAI activities are developed by the SCAI SHOCK Program Committee prior to and independent of commercial support. Members of the Education Committee reviewed and approved this activity, and those with relevant conflicts of interest recused themselves. Members of SCAI’s Continuing Medical Education Oversight Committee, clinicians in the field of cardiac catheterization and angiography, reviewed all educational materials and verified that the materials are fair, accurate, and free of commercial bias. 

Content Validation Statement
SCAI accepts the following Content Validation Statements and expects all persons involved in its professional education activities to abide by these statements for clinical care recommendations. All clinical and pharmacological recommendations are based on evidence accepted within the medical profession as adequate jurisdiction for their indications and contradictions in patient care. All research referenced to support or justify patient care recommendations conforms to accepted standards of experimental design, data collection and analysis.

SCAI's educational content is free of marketing or sales of products or services. Faculty will not actively promote or sell products or services that serve their professional or financial interests during accredited education. 

SCAI encourages faculty to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.

© 2021-2022 Society for Cardiovascular Angiography and Interventions (SCAI). All rights reserved.